Preprint / Version 1

Perspective on Accelerating the Mutation Rate of SARS-CoV-2 for a Better Way of COVID-19 Treatment

Enhanced Mutation Therapy of COVID-19




“Higher the mutation rate higher is the possibility to evolve” and “higher the possibility to evolve higher is the possibility of extinction”. Since +ssRNA virus replication is catalyse by their own polymerase lacking proofreading activity have high mutation rate; further enhancement of mutation of SARS-CoV-2 using nucleotide analogues would be helpful to fight against COVID-19


SARS-CoV-2, Mutation, Remdesivir, Nucleotide Analogues, COVID-19


Download data is not yet available.


Forster P, Forster L, Renfrew C and Forster M (2020) Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci USA, pii: 202004999.

Andersen KG, Rambaut A, Lipkin WI, Holmes EC and Garry RF (2020) The proximal origin of SARS-CoV-2. Nat Med, 26: 450-452.

Kim D, Lee JY, Yang JS, Kim JW, Kim VN and Chang H (2020) The architecture of SARS-CoV-2 transcriptome. Cell, pii: S0092-8674(20)30406-2.

Cao B, Wang Y, et al. (2020) A trial of lopinavir-ritonavir in adults Hospitalized with Severe Covid-19. N Engl J Med, Mar 18.

Grein J, Ohmagari N, et al. (2020) Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med, Apr 10.

Peck KM and Lauring AS (2018) Complexities of viral mutation rates. J Virol, 92(14). pii: e01031-17.

Lynch M, Ackerman MS, et al. (2016) Genetic drift, selection and the evolution of the mutation rate. Nat Rev Genet 17:704–714.

Vignuzzi M, Stone JK, et al. (2006) Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature, 439: 344–348.

Timm A and Yin J (2012) Kinetics of virus production from single cells. Virology, 424: 11-17.

Jordan PC, Stevens SK and Deval J (2018) Nucleosides for the treatment of respiratory RNA virus infections. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618764483.

Pachetti M, Marini B, et al. (2020) Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. J Transl Med. 18: 179.

Wang C, Liu Z, Chen Z, Huang X, Xu M, He T and Zhang Z (2020) The establishment of reference sequence for SARS-CoV-2 and variation analysis. J Med Virol, 2020 Mar 13.

Patra SK (2020) Outfitting COVID-19: An effective therapeutic approach. AIJR Preprints, 41: Version-1.

Jennifer Abbasi J (2020) The promise and peril of antibody testing for COVID-19. JAMA, online April 17, 2020.